PAXVAX, INC.
Redwood City, US
Find your way into PAXVAX, INC.
Sign up to see every warm intro you have to PAXVAX, INC.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PAXVAX, INC. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KJ
Kenneth J. KelleyFounder
Board
JC
James ConnollyBoard director
HB
Howard B. RosenBoard director
RT
Richard TongBoard director
HG
Henry G. Coit, Jr.Board director
PR
Phil RussellBoard director
Reported raises · per SEC filings
Form D private placements$40.9M disclosed across 2 rounds · 2013–2014
▶$34.9MraisedAug 2014 · 9 investors · PharmaceuticalsRule 506(b)
▶$34.9MraisedAug 2014 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- HENRY G. COIT, JR.Director
- JAMES CONNOLLYDirector
- RICHARD TONGDirector
- KENNETH J. KELLEYExecutive Officer, Director
- PHIL RUSSELLDirector
- HOWARD B. ROSENDirector
- Offering amount
- $35.5M
- Amount sold
- $34.9M
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedApr 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$6MraisedApr 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- James ConnollyDirector
- Howard B. RosenDirector
- Richard TongDirector
- Henry G. Coit, Jr.Director
- Kenneth J. KelleyExecutive Officer, Director
- Phil RussellDirector
- Offering amount
- $15M
- Amount sold
- $6M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.8M |
| Department of DefenseDefense Health Program | Phase II | 2015 | $1M |
| U.S. ArmyArmy | Phase I | 2014 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2012 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $548.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $298.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded PAXVAX, INC.?
- PAXVAX, INC. was founded by Kenneth J. Kelley.
- How much funding has PAXVAX, INC. raised?
- PAXVAX, INC. has disclosed $40.9M raised across 2 rounds.
- Where is PAXVAX, INC. headquartered?
- PAXVAX, INC. is headquartered in Redwood City, US.